What are the Challenges in Developing Responsive Drug Delivery Systems?
Despite their potential, several challenges remain in the development of effective responsive drug delivery systems:
Biocompatibility: Ensuring that nanomaterials do not cause adverse reactions in the body is a major concern. Stability: Maintaining the stability of nanomaterials and their drug payloads under physiological conditions is critical. Scalability: Producing these advanced materials on a large scale in a cost-effective manner is challenging. Regulatory Hurdles: Navigating the complex regulatory landscape for new nanomaterials and delivery systems can be daunting.
